AG002FP2

192185-72-1 | 2(1H)-Quinolinone, 6-[(R)-amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-chlorophenyl)-1-methyl-

AG002FP2

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	192185-72-1
Catalog Number	AG002FP2(AGN-PC-0QL1XV)
Chemical Name	2(1H)-Quinolinone, 6-[(R)-amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-chlorophenyl)-1-methyl-
IUPAC Name	6-[(R)-amino-(4-chlorophenyl)-(3-methylimidazol-4-yl)methyl]-4-(3-chlorophenyl)-1-methylquinolin-2-one
InChI	InChI=1S/C27H22Cl2N4O/c1-32-16-31-15-25(32)27(30,18-6-9-20(28)10-7-18)19-8-11-24-23(13-19)22(14-26(34)33(24)2)17-4-3-5-21(29)12-17/h3-16H,30H2,1-2H3/t27-/m1/s1
InChI Key	PLHJCIYEEKOWNM-HHHXNRCGSA-N
MDL Number	MFCD07772347
Molecular Formula	C27H22Cl2N4O
Molecular Weight	489.3958
SMILES	Clc1ccc(cc1)[C@](c1cncn1C)(c1ccc2c(c1)c(cc(=O)n2C)c1cccc(c1)Cl)N
UNII	MAT637500A
Synonyms	(R)-6-(amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl)-4-(3-chlorophenyl)-1-methyl-2(1H)-quinolinone, 2 (1H))-quinolinone,6-(amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl)-4-(3-chlorophenyl)-1-methyl-,(+)-, R 115777, R-115777, R115777, tipifarnib, Zarnestra, Tipifarnib, 192185-72-1, Zarnestra, R115777, R-115777, Tipifarnib (Zarnestra), UNII-MAT637500A, (R)-6-(Amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl)-4-(3-chlorophenyl)-1-methyl-2(1H)-quinolinone, 6-[(R)-amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-chlorophenyl)-1-methylquinolin-2(1H)-one, MAT637500A, (R)-( )-R115777, R-11577, IND 58359, 6-[(S)-AMINO(4-CHLOROPHENYL)(1-METHYL-1H-IMIDAZOL-5-YL)METHYL]-4-(3-CHLOROPHENYL)-1-METHYLQUINOLIN-2(1H)-ONE, D03720, 6-[(R)-amino-(4-chlorophenyl)-(3-methylimidazol-4-yl)methyl]-4-(3-chlorophenyl)-1-methylquinolin-2-one, JAN, Q-102509, Tipifarnib [USAN], R 115777, (R)-6-(amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl)-4-(3-chlorophenyl)-1-methylquinolin-2(1H)-one, 2 (1H))-Quinolinone,6-(amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl)-4-(3-chlorophenyl)-1-methyl-, (+)-, 2(1H)-Quinolinone,6-[(R)-amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-chlorophenyl)-1-methyl-, tipifarnib(r115777), Tipifarnib (USAN/INN), Tipifarnib [USAN:INN], tipifarnibum, Tipifarneb, CCRIS 9329, NSC702818, NSC-702818, PubChem22490, Tipifarnib - Zarnestra, (R)-TIPIFARNIB, AC1Q3OVC, AC1L4LN0, SCHEMBL8097, MLS006011105, GTPL8025, LX81, DTXSID5041140, Tipifarnib, >=98% (HPLC), CTK4E0919, R115777; TIPIFARNIB, 1x81, CHEBI:141969, BCPP000044, HMS3654B10, BCP02262, EX-A2346, KS-00001CS7, ABP000933, AN-483, BDBM50370385, s1453, ZINC24809155, AKOS027326864, CS-0475, DB04960, SB16693, NCGC00250406-01, HY-10502, SMR002530065, Tipifarnib; IND 58359; R115777, LS-184411, LS-187005, LS-187640, FT-0675247, SW219749-1, Tipifarnib(R115777)/zarnestraIND 58359, X1029, A25612, W-5357, 185T721, BRD-K62965247-001-01-5, Zarnestra, IND 58359, R115777, 192185-72-1, IND 58359;R115777;IND-58359;IND58359;R-115777;R 115777, (+)-(r)-6-[amino(4-chlorophenyl)(1-methyl-1h-imidazol-5-yl)methyl]-4-(3-chlorophenyl)-1-methyl-2(1h)-quinolinone, (R)-6-(Amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl)-4-(3-chlorophenyl)-1-methyl-2(1H)-quinolinone;R115777, 2 (1H))-Quinolinone,6-(amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl)-4-(3-chlorophenyl)-1-methyl-, 2 (1H))-Quinolinone,6-(amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl)-4-(3-chlorophenyl)-1-methyl-, 2(1H )-quinolinone, 2(1H)-Quinolinone, 6-[(R)-amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-chlorophenyl)-1-methyl-, 6-[(R)-Amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl}-4-(3-chlorophenyl)-1-methyl-2(1H)-quinolinone, 6-[(R)-amino-(4-chlorophenyl)-(3-methylimidazol-4-yl)methyl]-4-(3-chlorophenyl)-1-methyl-quinolin-2-one, Tipifarnib[USAN], D07NPS, C27H22Cl2N4O, CHEMBL289228, C27-H22-Cl2-N4-O, AR-1H0635, AR-1H0636, CID159324, Tipifarnib(Zarnestra)IND58359,R115777, A4227, (R)-R115777, A10935, Zarnestra, IND 58359, R115777, Tipifarnib, C402769, 2 (1H))-Quinolinone,6-(amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl)-4-(3-chlorophenyl)-1-methyl-, 2(1H)-quinolinone, 2 (1H))-quinolinone,6-(amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl)-4-(3-chlorophenyl)-1-methyl-,(+)-, 22041-25-4, 22041-28-7,

Complexity	785
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	1
Defined Bond Stereocenter Count	0
Exact Mass	488.117g/mol
Formal Charge	0
Heavy Atom Count	34
Hydrogen Bond Acceptor Count	3
Hydrogen Bond Donor Count	1
Isotope Atom Count	0
Molecular Weight	489.4g/mol
Monoisotopic Mass	488.117g/mol
Rotatable Bond Count	4
Topological Polar Surface Area	64.2A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0
XLogP3	4.1

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H315-H319-H335
Packing Group
Precautionary statements	P261-P305+P351+P338
UN Code

Certificate of Analysis

Lot Number